Browse the evidence

Small sustained changes in energy intake or expenditure do not produce large, long-term weight changes as predicted by the 3500-kcal rule due to physiological compensation.

Do not expect massive weight loss from tiny lifestyle tweaks like walking an extra mile or skipping two chips daily. Your body will compensate by lowering energy expenditure. To lose significant weight, you need larger, more substantial changes in energy intake or expenditure, or a combination of both, rather than relying on small, sustainable habits alone.

Estrogen directs fat distribution to subcutaneous gluteo-femoral depots in premenopausal women, which is protective against cardiometabolic risk, whereas estrogen deficiency (menopause) shifts distribution to visceral fat, increasing risk.

For women, where fat is stored matters more than total fat. Estrogen protects by storing fat in hips/thighs. After menopause, estrogen drops, and fat moves to the belly, increasing health risks. Managing visceral fat through diet and exercise is critical post-menopause.

Caloric restriction (CR) and dietary restriction (DR) extend lifespan and healthspan, largely by suppressing the IIS/mTOR axis, although CR may also act through mTOR-independent mechanisms.

Reducing calorie intake by 20-40% or restricting specific nutrients like protein or methionine can extend lifespan and healthspan in model organisms. This works partly by suppressing the mTOR pathway, but also through other mechanisms. For humans, this suggests that mindful eating, potentially focusing on protein quality and quantity, may offer longevity benefits.

Obesity results from a loss of homeostatic energy balance regulation driven by evolutionary mismatch and peripheral signals (leptin/insulin) failing to inhibit orexigenic pathways (NPY/AgRP) due to resistance mechanisms.

Your body has a biological defense against weight loss involving hormones like leptin and neuropeptides like NPY. In obesity, these signals often fail (resistance), making it harder to lose weight through willpower alone. Understanding this helps shift the focus from 'eating less' to addressing the underlying hormonal signaling and environmental factors.

Rare and low-frequency coding genetic variants in genes such as MC4R, GIPR, and KSR2 are significantly associated with Body Mass Index (BMI), with effect sizes approximately ten times larger than those of common variants.

Your genetics play a role in your weight, but for most people, common lifestyle factors (diet, activity) are far more impactful than rare genetic mutations. If you have a known high-impact mutation like MC4R p.Tyr35Ter, you may need more aggressive or specialized medical interventions, but for the general population, focusing on energy balance remains the most effective strategy.

Catecholamines (adrenaline and noradrenaline) stimulate lipolysis by binding to beta-adrenergic receptors, increasing cAMP, and activating Protein Kinase A (PKA) to phosphorylate Hormone-Sensitive Lipase (HSL) and Perilipin.

Physical activity and stress increase catecholamines, which directly trigger fat breakdown. This is the body's primary mechanism for mobilizing energy during exercise or fasting. The process involves breaking down triglycerides into fatty acids and glycerol for use by other organs.

GLP-1 receptor agonists and DPP-4 inhibitors both have a low risk of hypoglycemia when used as monotherapy due to their glucose-dependent mechanism of action.

Both GLP-1 injections and DPP-4 inhibitor pills are safe in terms of hypoglycemia risk when taken alone. They only work to lower blood sugar when it is elevated, unlike insulin or sulphonylureas which can cause dangerous lows if you skip a meal.

Early quadriceps strength loss after total knee arthroplasty is predominantly caused by failure of voluntary muscle activation (neural inhibition) rather than muscle atrophy.

After knee replacement, your leg is weak not just because the muscle shrank, but because your brain is failing to fully recruit it. Since pain isn't the main reason for this 'shutdown,' simply waiting for pain to disappear won't fix your strength. You need active rehabilitation that specifically targets retraining your nervous system to fire the muscle fully, such as high-intensity contractions or neuromuscular electrical stimulation.

Systemic and hepatic insulin resistance is the central pathophysiological mechanism driving the development and progression of metabolic dysfunction-associated fatty liver disease (MAFLD).

Focus on improving insulin sensitivity through weight management, physical activity, and dietary quality. Since insulin resistance is the root cause of MAFLD, interventions that lower insulin levels and improve glucose handling (like exercise and reducing refined carbohydrates) are the most effective way to prevent or reverse liver fat accumulation.

Insulin resistance in adipose tissue leads to increased free fatty acid (FFA) release, which drives hepatic fat accumulation and inflammation.

Reducing visceral fat through caloric deficit and exercise improves adipose tissue insulin sensitivity, thereby reducing the flood of FFAs to the liver and lowering liver fat.

U.S. nutritional surveillance data from NHANES (1971–2010) systematically underreports caloric energy intake, rendering population-level trends in caloric consumption invalid for public health policy.

Do not rely on self-reported dietary recalls (like 24-hour recalls) to track population-level calorie trends or to guide broad public health policies. The data is systematically flawed by underreporting, especially for high-calorie foods. For individual tracking, be aware that you are likely underreporting by ~10-18% of your total expenditure, and this bias increases with higher BMI.

Hip circumference is a poor proxy for trunk fat and a good proxy for leg fat and lean mass, making waist-to-hip ratio (WHR) a complex metric influenced by both harmful trunk fat and protective leg tissue.

Use waist circumference to monitor abdominal fat, but understand that hip size reflects leg muscle and fat. A high WHR might mean high trunk fat OR low leg mass. DXA scans provide the clearest picture.

Ghrelin is the primary gastric hormone responsible for stimulating appetite (orexigenic effect) by crossing the blood-brain barrier and signaling via vagal afferents, while leptin (primarily from adipose tissue, some from stomach) acts as an anorexigenic signal.

Ghrelin is your stomach's 'hunger hormone,' which rises before meals to stimulate appetite. While it plays a key role, simply trying to block it has not been an effective weight loss strategy so far. Appetite is regulated by a complex interplay of hormones (ghrelin, leptin, CCK, GLP-1) and neural signals.

Genetic variants associated with morningness (chronotype) and sleep duration are located near genes regulating circadian rhythms (RGS16, PER2) and photoreception (INADL, HTR6), indicating a biological basis for individual differences in sleep timing.

Your tendency to be a 'morning lark' or 'night owl' is largely determined by your genetics, specifically genes like RGS16 and PER2 that regulate your internal clock. Instead of fighting this predisposition, try to align your work and sleep schedules with your natural chronotype to improve sleep quality and metabolic health.

Genetic variants near the VRK2 gene are associated with shorter sleep duration, with each allele associated with approximately 1.6 to 2.0 minutes less sleep.

Genetic variants near the VRK2 gene are associated with slightly shorter sleep duration (1.6-2.0 minutes less per allele). While this is a statistically significant finding, the effect size is small and likely has minimal practical impact on an individual's total sleep time.

Rapid weight gain in infancy and the second year of life, exceeding normal growth standards, is associated with an increased risk of subsequent obesity.

Monitor your infant's growth using standard growth charts. Avoid rapid weight gain that exceeds these standards, as it is linked to a higher risk of obesity later in life. Focus on balanced feeding practices rather than forcing extra food.

Obesity is a complex, heritable disorder resulting from the interplay of genetic susceptibility, epigenetics, metagenomics, and environmental factors, rather than solely lifestyle choices.

Recognize that obesity is a biological condition influenced by your genetics and environment, not just a failure of willpower. This understanding can reduce stigma and guide you toward evidence-based treatments, such as medications or surgeries, which may be necessary for those with specific genetic predispositions.

Doubly labelled water (DLW) is the most accurate method for measuring total daily energy expenditure in free-living subjects, providing an error of less than 7-8% over 7-21 days, whereas chamber-based systems are more accurate for long-term measurements but fail to reflect real-life behaviors due to confinement constraints.

For accurate assessment of total daily energy expenditure in real-world settings, doubly labelled water is the gold standard. However, it is expensive and does not break down energy use by activity type, so it is primarily used in research rather than clinical practice.

Urolithin A extends lifespan and improves muscle function in preclinical models by activating mitophagy and reducing inflammation.

This node describes animal studies. While it confirms the biological plausibility of UA's benefits, it does not directly translate to a human dosing protocol. It supports the use of UA in humans as described in Node 1.

Dual-energy X-ray absorptiometry (DXA) is the current reference standard for assessing body composition in clinical research due to its accuracy, low radiation, and ability to distinguish between fat mass, lean mass, and bone mineral content, although it has limitations regarding hydration status assumptions.

If you need an accurate assessment of your body composition (fat vs. muscle vs. bone), DXA is the most accessible and reliable clinical standard available today. It provides a detailed breakdown that BMI cannot, helping to identify hidden risks like visceral fat or muscle loss.

Chronic low-grade inflammation (inflammaging) acts as a bidirectional driver that exacerbates all other hallmarks of aging, creating a vicious cycle that accelerates biological aging and age-related diseases.

Chronic, low-grade inflammation is a central accelerator of aging. While not an intervention itself, understanding 'inflammaging' highlights the importance of lifestyle factors (diet, exercise) that modulate immune response and reduce this persistent inflammatory state, thereby potentially slowing the progression of age-related diseases.

Overtraining Syndrome (OTS) is diagnosed by excluding organic diseases and confounding factors (such as caloric restriction, iron deficiency, or infections) rather than by a single positive diagnostic marker, as no current test meets all diagnostic criteria.

If you are experiencing unexplained performance decline and fatigue, do not rely on a single blood test to diagnose 'overtraining.' Instead, work with a professional to systematically rule out other causes like illness, nutrient deficiencies (iron, magnesium), or caloric deficits. The diagnosis is made by excluding these factors and observing a prolonged maladaptation to training stress.

Bariatric/metabolic surgery induces rapid type 2 diabetes remission through weight-independent mechanisms, primarily involving altered gut hormone secretion (GLP-1, PYY), bile acid metabolism, and intestinal glucose disposal, occurring before significant weight loss.

For individuals with T2DM, bariatric surgery offers a potent, rapid improvement in blood sugar control that is driven by hormonal and metabolic changes in the gut, not just weight loss. This makes it a highly effective treatment for eligible candidates, particularly those who have not achieved remission through lifestyle changes alone. However, it is not suitable for everyone, especially those with long-standing diabetes and depleted insulin production.

In typical obesity, elevated leptin levels fail to suppress appetite or increase energy expenditure due to leptin resistance, and high-fat diets can exacerbate this resistance.

In common obesity, your body produces high levels of leptin, but your brain stops listening to it. This is called leptin resistance. It means you won't feel full or burn more energy just because you have more fat tissue. High-fat diets can make this resistance worse.